Pharmaceuticals News and Research

RSS

Campaign seeks to counter influence of pharma sales reps

The Boston Globe on Monday examined the Independent Drug Service project, a $1 million campaign in Pennsylvania that sends consultants to inform physicians about the effectiveness of different medications based on scientific evidence to "combat the sales pitches" of pharmaceutical companies.

28 Feb 2007

Cancer Research UK secures fenretinide orphan drug licence

A previously shelved drug could prove effective for treating a group of rare childhood cancers, and Cancer Research UK today announced it has been granted exclusive marketing rights for the drug in these indications by the European Commission and the Food and Drug Administration (FDA).

27 Feb 2007

Drug industry influences breast cancer research

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

27 Feb 2007

Financial interest of drug industry influences research results

According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.

26 Feb 2007

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

26 Feb 2007

Danish court injunction prohibits sale of generic Lipitor

Pfizer has announced that a Danish court has granted a preliminary injunction against Nomeco A/S -- the largest pharmaceutical wholesaler in Denmark -- that prohibits the sale of a generic version of Lipitor by generics manufacturer Ranbaxy.

25 Feb 2007

Pharmaceutical companies overcharging federal health care programs

Pharmaceutical companies have been systematically overcharging federal health care programs, costing taxpayers billions of dollars, according to federal officials, members of Congress and an advocacy group, the Newhouse News/Richmond Times-Dispatch reports.

25 Feb 2007

Apolipoprotein C1 protein linked to elevated BMI in people of American Indian and Mexican ancestry

University of Minnesota researchers have discovered a variant of a common blood protein, apolipoprotein C1, in people of American Indian and Mexican ancestry that is linked to elevated body mass index (BMI), obesity and Type 2 diabetes.

22 Feb 2007

Blueprint for influenza pandemic

The American Public Health Association (APHA) today released its blueprint for strengthening the nation's pandemic preparedness, amid persistent concerns about a potential influenza pandemic.

22 Feb 2007

Merck to register, lower cost of antiretroviral Atripla in developing countries

Pharmaceutical company Merck on Friday said that it will begin registering the antiretroviral drug Atripla in developing countries and that it will lower the cost of the drug in countries with high HIV prevalence, the Bergen Record reports.

21 Feb 2007

Merck conducts trial of experimental HIV vaccine among sex workers in the Dominican Republic

The pharmaceutical company Merck is conducting Phase II clinical trials of its experimental HIV vaccine among 175 commercial sex workers in the Dominican Republic, the AP/Long Island Newsday reports.

21 Feb 2007

Provectus receives notice of allowance for acne product

Provectus Pharmaceuticals, Inc. announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application covering novel acne medications, including the Company's invisible, solid acne treatment, Pure-Stick, which is an over- the-counter (OTC) product.

21 Feb 2007

New changes for UK pharmaceutical regulation

The Chief Pharmaceutical Officers from England, Scotland and Wales came together today to reveal plans for historic changes to the regulation of the pharmacy profession.

21 Feb 2007

Battle looming between NHS and pharma giants

According to the Office of Fair Trading (OFT) in Britain, the National Health Service (NHS) is paying far too much to drug companies for branded medicines.

20 Feb 2007

Thailand threatens big pharma companies

Thailand's minister for health has reportedly threatened to override international patents on even more drugs if the big pharmaceutical manufacturers do not significantly cut their prices.

19 Feb 2007

Countries should find balance between affordable drugs, development incentives, WHO Director-General says in letter to Thai Health Minister

World Health Organization Director-General Margaret Chan in a letter to Thai Health Minister Mongkol na Songkhla said that although the Thai government was fully within its rights to issue a compulsory license for Abbott Laboratories antiretroviral drug Kaletra, countries should find the "right balance" between providing affordable medicines and incentives for drug companies to develop new treatments.

19 Feb 2007

Legislation introduced that would give FDA authority to approve generic versions of biotechnology drugs

Lawmakers in the House and Senate on Wednesday introduced a bill that would allow FDA to approve generic versions of biotechnology medications, USA Today reports.

19 Feb 2007

Health care industry groups lobby Presidential candidates

Roll Call on Wednesday examined how health care is "quickly becoming a cornerstone" of 2008 presidential candidates' domestic proposals and how "health industry groups and their lobbyists already are trying to make sure candidates in both parties keep their interests in mind along the campaign trail."

19 Feb 2007

Novel spray method for delivering tuberculosis vaccine

Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods.

18 Feb 2007